Thus, from our analysis, it was revealed that the differences in the expression of nuclear p53 in HNPMI‐treated HT‐29 and DLD‐1 cells might be due to the different staged CRC cell lines, which implies that the pathogenesis also might vary (Rosati et al., 2004). The gene discussed is TP53; the disease is colorectal carcinoma.